Advertisement

Topics

Latest Endocrinology NewsRSS

06:25 EST 20th February 2017 | BioPortfolio

MICROBIOME INTESTINAL : Façonné par les gènes, il fait le risque métabolique - Cell Reports

Cette communauté de microorganismes qui habite l'intestin, connue sous le nom de microbiome intestinal travaille en tandem avec les gènes de l'organisme hôte pour réguler la sécrétion d'insuline, l'hormone clé qui régule la glycémie et, en cas de résistance, est en cause dans le diabète et autres troubles métaboliqu...

Ascendis Pharma A/S ASND Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryAscendis Pharma A/S Ascendis is a pharmaceutical company that offers drug discovery and development services. The company's products include transcon growth hormone, transcon treprostinil, transcon prodrugs, and transcon ranibizumab. Its transcon ranibizumab product use for the treatment of age related macular edema amd and other ophthalmic indications. Ascendis conducts research and develo...

Parents worried about passing on genetic disorders to their children have hope: Gene editing

Researchers find breastfeeding can reduce women’s risk of metabolic syndrome

Researchers from Hallym University's College of Medicine in Seoul Korea found in a new study that

Risperdal Gynecomastia Lawsuits Move Forward, As Pennsylvania Mass Tort Program Schedules March Meeting, Bernstein Liebhard LLP Reports

NEW YORK, Feb. 17, 2017 /PRNewswire/ -- Risperdal lawsuits involving gynecomastia (male breast growth) and other side effects allegedly associated with use of the atypical antipsychotic medication continue to move forward in the Philadelphia Court of Common Pleas, where the state's Risperdal docket has been centralized in a mass tort program. According to a notice posted on the Court's websit...

Global ENT Endoscopic and Bronchoscopic Devices Market 20172021 [Updated: 07022017] Prices from USD $3500

About ENT Endoscopy and Bronchoscopy DevicesThe ENT endoscopes market is driven by the newgeneration flexible video scopes. These are less traumatic and provide improved visualization for the surgeons. The increasing cases of sinusitis, ear infections, and sleep disorders are driving the growth of the ENT endoscopes market. Obesity and older adult population contribute to the increasing use of the...

Frontier Pharma: Versatile Innovation in Immunology Large Therapy Area Pipeline with a High Degree of Repositioning Potential [Updated: 05012017] Prices from USD $6995

Frontier Pharma: Versatile Innovation in Immunology Large Therapy Area Pipeline with a High Degree of Repositioning PotentialSummaryImmunology is a large therapy area characterized by disorders of the immune system specifically an aberrant immune response against healthy tissues present in the body, leading to chronic or acute inflammation. Depending on the specific site affected, this can lead ...

Ascendis Announces Publication Of Comprehensive Results From Randomized, Active-Controlled Phase 2 Trial Of Once-Weekly Transcon Growth Hormone In Pediatric Patients

  Life Sciences Jobs   ...

Long-term weight gain linked to esophageal, gastric cancers

Individuals who become overweight in their twenties and progress to obesity later in life may have a threefold increased risk for developing esophageal and gastric cardia adenocarcinomas compared with those who maintain a healthy weight, according to new research published in the British Journal of Cancer.“This study highlights how weight gain over the course of our lives can increase the risk o...

Brian Ellis Michael, MD, is recognized by Continental Who's Who

NEW OXFORD, Pa., Feb. 16, 2017 /PRNewswire/ -- Brian Ellis Michael, MD, is recognized by Continental Who's Who as a Pinnacle Professional in the field of Healthcare. Dr. Michael is an Endocrinologist with Wellspan York Hospital. Offering an array of healthcare services including walk-in care services, rehabilitation, durable medical equipment, diagnostic imaging and more, Wellspan York Ho...

Ascendis Pharma A/S Announces Publication of Comprehensive Results from Randomized, Active-Controlled Phase 2 Trial of Once-Weekly TransCon Growth Hormone in Pediatric Patients

COPENHAGEN, Denmark, Feb. 16, 2017 /PRNewswire/ -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced the publication of its previously presented pediatric phase 2 trial of TransCon Growth Hormone in the Journal of Clinical Endocrinology and Metabolism. Th...

Postmenopausal hormone therapy ineffective for Alzheimer disease

Postmenopausal hormone therapy was not associated with decreased risk for Alzheimer disease; however, long-term self-reported use was associated with reduced risk. “Women have [Alzheimer’s disease] more often than men either due to their increased life expectancy or decline in sex steroid hormone levels around menopause, although some small studies have not detected this sex difference,” Bus...

How a Plant Resists Drought

One potential way to protect crops from the worsening droughts that will be brought on by climate change would be to spray them with a compound that induces plants to become more drought resistant. Researchers have recently identified the key molecular mechanism that allows plants to be more drought resistant: The hormone abscisic acid (ABA) binds to a protein, the PYL receptor, which enables a pl...

Janet Whitney, M.S., LMFT, to Discuss Sovereign Health's Eating Disorders Program During National Eating Disorders Awareness Week

SAN CLEMENTE, Calif., Feb. 16, 2017 /PRNewswire/ -- Sovereign Health, a national behavioral health system, is proud to announce that Janet Whitney, M.A., LMFT, Eating Disorders Program Consultant at Sovereign Health of San Clemente, will be presenting "Speaking to the Heart of People with Eating Disorders." The event featuring Ms. Whitney will be held on Tuesday, Feb. 28, from 5:00 p.m. to 6:...

Rhythm Announces Completion of $41 Million Mezzanine Financing

BOSTON, Feb. 16, 2017 /PRNewswire/ -- Rhythm, a biopharmaceutical company developing peptide therapeutics for rare genetic deficiencies that result in life-threatening metabolic disorders, today announced the completion of a $41 million mezzanine round of financing with existing investors including Deerfield Management, Ipsen, OrbiMed, MPM Capital, New Enterprise Associates, Pfizer Venture In...

Success is Contagious, SottoPelle® Ranked #1 Hormone Therapy Clinic Again

SCOTTSDALE, Ariz., Feb. 16, 2017 /PRNewswire/ -- Ranking Arizona® lists the best businesses in Arizona, and has again announced that SottoPelle® has earned the number one spot among Hormone Therapy Clinics in Arizona in its 2017 edition. This is the second year in a row that SottoPelle® has been ranked #1. The selection process was based on various criterion. "The companies that are voted i...

New Parkinson’s & Movement Disorders Program Launches

Innovative Silverado program to include brain health components that benefit people with movement disorders. IRVINE, CA (PRWEB) February 15, 2017 Silverado today announces an innovative program specifically designed to provide quality of life to people with Parkinson’s disease and other movement disorders. Available in Houston and Chicago, the specialized program was designed based on the lates...

Sovereign Health Discusses Eating Disorders in New Television Interview

SAN CLEMENTE, Calif., Feb. 15, 2017 /PRNewswire/ -- Sovereign Health, a national behavioral health system, announces a new television interview about its Eating Disorders Program. The interview, featuring Janet Whitney, M.A., LMFT, Eating Disorders Program Consultant at Sovereign Health of San Clemente, was first broadcast live on the NBC affiliate KMIR's program "Desert Living" on Wednesday,...

Autism Center at Rush Seeking Participants for Social Skills Study

CHICAGO, Feb. 15, 2017 /PRNewswire/ -- Chicagoland families and providers with children on the autism spectrum are invited to enroll in a groundbreaking social skills study.  The Autism Center at Rush University Medical Center is actively recruiting children ages 8-11 with Autism Spectrum Disorder (ASD) to participate in a study evaluating how behavioral therapy and the hormone oxytocin ...

The FDA has Approved Tirosint-SOL, Levothyroxine in Liquid Solution for the American Market, IBSA Patent

MILAN, February 15, 2017 /PRNewswire/ --  IBSA announced today that the US Food and Drug Administration (FDA) has approved Tirosint-SOL (levothyroxine sodium oral solution), a liquid form of levothyroxine for the following two conditions: hypothyroidism and TSH suppression in the management of some thyroid cancers.      (Logo: http://mma.prnewswire.com/media/466766...

Seeking to reduce genetic disorders, Iran orders mandatory premarital DNA screens

Every day, 80 infants with some form of disability are born in [Iran]. That equals to over 30,000 new disabilities per year. … Genetic testing before marriage has been made mandatory [in Iran] in the next economic, social and cultural development plan (2016-2021) which will come into effect in March (one year late), reports [the […] The post

DIABÈTE : L'hormone anti-âge qui prévient les maladies du rein et du coeur - Diabetologia

Cette étude menée par une équipe du King's College de Londres montre que les patients atteints de diabète et de maladie rénale aux premiers stades souffrent aussi d'une déficience en hormone anti-âge : la fameuse hormone Klotho. Cette observation, documentée dans Diabetologia, la revue de l'Association européenne pour l'étude du ...

Sleep Aids: Technologies and Global Markets

LONDON, Feb. 13, 2017 /PRNewswire/ -- Use this report to: - Analyze the current market dynamics and evaluate the effect of strategic factors such as technology-driven change and industry consolidation of sleep aids and technologies. - Review the main products in each sector and plan a product entry strategy in line with the strengths and weaknesses of the competition. - Ass...

Global Hearing Disorders Partnering 2010 to 2017

LONDON, Feb. 13, 2017 /PRNewswire/ -- Summary Provides understanding and access to the hearing disorders partnering deals and agreements entered into by the worlds leading healthcare companies. Description The Global Hearing Disorders Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's ...

Aeterna Zentaris Announces Plans to Pursue FDA Registration of Macrilen™

CHARLESTON, S.C.–(BUSINESS WIRE)–#AEZ–Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the “Company”) today announced that, following a comprehensive review of data obtained from the confirmatory Phase 3 clinical trial of Macrilen™ (macimorelin) for the evaluation of growth hormone deficiency in adults … Continue reading → Cet article Aeterna Zentaris Announces ...

Quick Search
Advertisement
 

review and buy Endocrinology market research data and corporate reports here